AAAAAA
Results: 1-25/77
Authors:
Hoedemaeker, RF
van der Kwast, TH
Boer, R
de Koning, HJ
Roobol, M
Vis, AN
Schroder, FH
Citation: Rf. Hoedemaeker et al., Pathologic features of prostate cancer found at population-based screeningwith a four-year interval, J NAT CANC, 93(15), 2001, pp. 1153-1158
Authors:
Schroder, FH
Wildhagen, MF
Citation: Fh. Schroder et Mf. Wildhagen, Screening for prostate cancer: evidence and perspectives, BJU INT, 88(8), 2001, pp. 811
Authors:
Blijenberg, BG
Yurdakul, G
Van Zelst, B
Bangma, CH
Wildhagen, MF
Schroder, FH
Citation: Bg. Blijenberg et al., Discordant performance of assays for free and total prostate-specific antigen in relation to the early detection of prostate cancer, BJU INT, 88(6), 2001, pp. 545-550
Authors:
Van der Cruijsen-Koeter, IW
Wildhagen, MF
De Koning, HJ
Schroder, FH
Citation: Iw. Van Der Cruijsen-koeter et al., The value of current diagnostic tests in prostate cancer screening, BJU INT, 88(5), 2001, pp. 458-466
Authors:
Schroder, FH
Citation: Fh. Schroder, Prostate cancer - Chairman's introduction, EUR J CANC, 37, 2001, pp. S117-S118
Authors:
Schroder, FH
Citation: Fh. Schroder, Prostate cancer: natural history and surgical treatment of localised disease, EUR J CANC, 37, 2001, pp. S127-S136
Authors:
Madalinska, JB
Essink-Bot, ML
de Koning, HJ
Kirkels, WJ
van der Maas, PJ
Schroder, FH
Citation: Jb. Madalinska et al., Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer, J CL ONCOL, 19(6), 2001, pp. 1619-1628
Authors:
Bangma, CH
Huland, H
Schroder, FH
van Cangh, PJ
Citation: Ch. Bangma et al., Early diagnosis and treatment of localized prostate cancer, EUR UROL, 40(3), 2001, pp. 1-10
Authors:
Schroder, FH
Citation: Fh. Schroder, Diagnosis, characterization and potential clinical relevance of prostate cancer detected at low PSA ranges, EUR UROL, 39, 2001, pp. 49-53
Authors:
Schroder, FH
Citation: Fh. Schroder, Online First publication (from issue 29/4 on), UROL RES, 29(3), 2001, pp. 143-143
Authors:
de Water, R
Leenen, PJM
Noordermeer, C
Nigg, AL
Houtsmuller, AB
Kok, DJ
Schroder, FH
Citation: R. De Water et al., Cytokine production induced by binding and processing of calcium oxalate crystals in cultured macrophages, AM J KIDNEY, 38(2), 2001, pp. 331-338
Authors:
Collette, L
Studer, UE
Schroder, FH
Denis, LJ
Sylvester, RJ
Citation: L. Collette et al., Why phase III trials of maximal androgen blockade versus castration in M-1prostate cancer rarely show statistically significant differences, PROSTATE, 48(1), 2001, pp. 29-39
Authors:
Vis, AN
Hoedemaeker, RF
Roobol, M
van der Kwast, TH
Schroder, FH
Citation: An. Vis et al., Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml), PROSTATE, 47(4), 2001, pp. 252-261
Authors:
Madalinska, JB
Essink-Bot, ML
de Koning, HJ
Kirkels, WJ
van der Maas, PJ
Schroder, FH
Citation: Jb. Madalinska et al., Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment, PROSTATE, 46(2), 2001, pp. 87-97
Authors:
Vis, AN
Hoedemaeker, RF
van der Kwast, TH
Schroder, FH
Citation: An. Vis et al., Defining the window of opportunity in screening for prostate cancer: Validation of a predictive tumor classification model, PROSTATE, 46(2), 2001, pp. 154-162
Authors:
Dohle, GR
Schroder, FH
Citation: Gr. Dohle et Fh. Schroder, Ultrasonographic assessment of the scrotum - Reply, LANCET, 357(9257), 2001, pp. 721-722
Authors:
Incrocci, L
Madalinska, JB
Essink-Bot, ML
Van Puten, WLJ
Koper, PCM
Schroder, FH
Citation: L. Incrocci et al., Sexual functioning in patients with localized prostate cancer awaiting treatment, J SEX MAR T, 27(4), 2001, pp. 353-363
Authors:
Schroder, FH
Roobol-Bouts, M
Vis, AN
van der Kwast, T
Kranse, R
Citation: Fh. Schroder et al., Prostate-specific antigen-based early detection of prostate cancer - Validation of screening without rectal examination, UROLOGY, 57(1), 2001, pp. 83-90
Authors:
Van Brussel, JP
Van Steenbrugge, GJ
Van Krimpen, C
Bogdanowicz, JFAT
Van Der Kwast, TH
Schroder, FH
Mickisch, GHJ
Citation: Jp. Van Brussel et al., Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer, J UROL, 165(1), 2001, pp. 130-135
Authors:
Jimenez, N
Jongsma, J
Calvo, A
van der Kwast, TH
Treston, AM
Cuttitta, F
Schroder, FH
Montuenga, LM
van Steenbrugge, GJ
Citation: N. Jimenez et al., Peptidylglycine alpha-amidating monooxygenase- and proadrenomedullin-derived peptide-associated neuroendocrine differentiation are induced by androgen deprivation in the neoplastic prostate, INT J CANC, 94(1), 2001, pp. 28-34
Authors:
Vis, AN
Hoedemaeker, RF
Roobol, M
Schroder, FH
van der Kwast, TH
Citation: An. Vis et al., The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma - An evaluation from a randomized, population-basedstudy of screening for prostate cancer, CANCER, 92(3), 2001, pp. 524-534
Authors:
Alers, JC
Krijtenburg, PJ
Vis, AN
Hoedemaeker, RF
Wildhagen, MF
Hop, WCJ
van der Kwast, TH
Schroder, FH
Tanke, HJ
van Dekken, H
Citation: Jc. Alers et al., Molecular cytogenetic analysis of prostatic adenocarcinomas from screeningstudies - Early cancers may contain aggressive genetic features, AM J PATH, 158(2), 2001, pp. 399-406
Authors:
Schroder, FH
van der Cruijsen-Koeter, I
Citation: Fh. Schroder et I. Van Der Cruijsen-koeter, The European Randomized Study of Screening for Prostate Cancer (ERSPC), CURR CLIN U, 2001, pp. 291-310
Authors:
Schroder, FH
Citation: Fh. Schroder, Editor's comment, BJU INT, 85(1), 2000, pp. I-II
Authors:
Nijs, HGT
Essink-Bot, ML
DeKoning, HJ
Kirkels, WJ
Schroder, FH
Citation: Hgt. Nijs et al., Why do men refuse or attend population-based screening for prostate cancer?, J PUBL H M, 22(3), 2000, pp. 312-316